ASX Growth Stocks With High Insider Ownership That Stand Out

The Australian market has shown a mixed performance, with the ASX200 closing slightly up at 7,942 points, driven by gains in the IT and Health Care sectors. In this fluctuating environment, identifying growth companies with high insider ownership can be particularly appealing to investors seeking alignment between management and shareholder interests.

Top 10 Growth Companies With High Insider Ownership In Australia

Click here to see the full list of 94 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Accent Group (ASX:AX1)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Accent Group Limited operates in the retail, distribution, and franchise sectors for lifestyle footwear, apparel, and accessories across Australia and New Zealand with a market cap of A$1.02 billion.

Operations: Accent Group's revenue is derived from its retail segment, which generated A$1.30 billion, and its wholesale segment, contributing A$475.92 million.

Insider Ownership: 14.8%

Accent Group, with significant insider ownership, has shown steady growth with recent half-year sales reaching A$775.96 million and net income of A$47.18 million. Despite a decrease in interim dividend to A$0.055 per share, the company trades at a substantial discount to its estimated fair value and is expected to grow earnings by 13.27% annually, outpacing the Australian market average. Recent board changes could enhance strategic direction and governance oversight.

• Take a closer look at Accent Group's potential here in our earnings growth report.
• Our expertly prepared valuation report Accent Group implies its share price may be lower than expected.

Botanix Pharmaceuticals (ASX:BOT)

Simply Wall St Growth Rating: ★★★★★★

Overview: Botanix Pharmaceuticals Limited is involved in the research and development of dermatology and antimicrobial products across Australia and the United States, with a market cap of A$867.17 million.

Operations: The company generates revenue of A$2.07 million from its research and development activities in dermatology and antimicrobial products.

Insider Ownership: 10%

Botanix Pharmaceuticals, recently added to the S&P/ASX 300 and Small Ordinaries indices, exhibits potential for substantial growth despite a challenging financial backdrop. The company is forecasted to achieve significant revenue growth of over 100% annually and become profitable within three years. However, it faces hurdles with a recent net loss of A$30.89 million and insider selling activity. Trading significantly below its fair value estimate, Botanix remains an intriguing prospect in the Australian market.

• Click here and access our complete growth analysis report to understand the dynamics of Botanix Pharmaceuticals.
• Our valuation report here indicates Botanix Pharmaceuticals may be overvalued.

Flight Centre Travel Group (ASX:FLT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Flight Centre Travel Group Limited is a global travel retailing company offering services for both leisure and corporate sectors across various regions, with a market capitalization of A$3.24 billion.

Operations: The company generates revenue through its leisure segment, contributing A$1.38 billion, and its corporate segment, which accounts for A$1.13 billion.

Insider Ownership: 13.6%

Flight Centre Travel Group demonstrates growth potential with earnings forecasted to increase by 23.1% annually, outpacing the broader Australian market. Recent insider buying suggests confidence in its future prospects, despite a decline in profit margins from 6% to 4.1%. The company trades at 31.6% below its fair value estimate and announced a dividend of A$0.11 per share, though it's not well covered by free cash flows, highlighting both opportunities and challenges for investors.

• Navigate through the intricacies of Flight Centre Travel Group with our comprehensive analyst estimates report here.
• Our valuation report unveils the possibility Flight Centre Travel Group's shares may be trading at a discount.

Next Steps

• Reveal the 94 hidden gems among our Fast Growing ASX Companies With High Insider Ownership screener with a single click here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com